Today: 23 May 2026
Alphabet (GOOG) stock lifts after-hours as $15 billion bond sale looms for AI buildout

Alphabet (GOOG) stock lifts after-hours as $15 billion bond sale looms for AI buildout

New York, Feb 9, 2026, 16:35 EST — After-hours trading.

  • Alphabet’s Class C stock edged 0.4% higher in late trading.
  • Bloomberg says Google’s parent is eyeing a $15 billion investment-grade bond offering, with demand surging—orders have already cleared $100 billion.
  • Investors are sizing up new borrowing as Alphabet lays out much bigger spending plans for 2026.

Alphabet’s non-voting Class C shares (GOOG) edged up 0.4% to $324.40 in late trading Monday, following a Bloomberg News report that the Google parent is aiming to raise roughly $15 billion in a U.S. investment-grade bond offering. GOOG moved in a $317.95-to-$327.72 range on the day, with volume landing near 25.9 million shares.

The debt maneuver hits a nerve for big tech. Investors still back the growth narrative, but now they’re pressing for answers—how steep will the AI tab get, and ultimately, who’s left to pay?

Alphabet stands out among “hyperscalers”—the group of large cloud players ramping up their investments in chips, servers, and power infrastructure. How these companies finance that expansion matters; it changes how much cash ends up in buybacks, dividends, or gets plowed back into capital spending.

Stocks broadly pushed upward. The SPDR S&P 500 ETF (SPY) posted gains of roughly 0.5%. Over in tech, the Invesco QQQ Trust (QQQ) advanced around 0.8%.

Alphabet jumped out front last week, laying out a big spending plan and reporting quarterly numbers that showed its cloud business is still firing. “We’re seeing our AI investments and infrastructure drive revenue and growth across the board,” CEO Sundar Pichai said in the earnings release. Capital expenditures for 2026 are now projected between $175 billion and $185 billion. Alphabet reported $113.8 billion in revenue for the quarter, and Google Cloud sales surged 48% to $17.7 billion. The board also approved a $0.21 dividend for shareholders of record as of March 9, with payment set for March 16. SEC

“Investment-grade” in bond talk refers to higher-rated corporate paper—usually the stuff big institutions go for, using U.S. Treasuries as their benchmark. Alphabet is said to be eyeing a deal with several maturities, splitting the offering into different tranches to reach various pools of buyers simultaneously.

Investors have shown clear interest so far. According to Bloomberg, orders for the bond offering had already surpassed $100 billion, with the 2066 tranche initially pitched at roughly 1.2 percentage points above Treasuries. The deal, which could be split into as many as seven parts, drew plenty of attention. Alphabet hasn’t commented, and Reuters was unable to confirm Bloomberg’s report.

Still, there’s risk on the table. Should rates climb or credit spreads stretch out, those big, late-cycle deals quickly get pricier. Suddenly, debt-fueled AI expansions can look like a burden if the revenue bump doesn’t keep up with the outlay — the market won’t wait around.

Now, all eyes turn to the final pricing and size details for Alphabet’s bond offering, plus whether spreads stay in line once the deal launches. Investors are also eyeing March 9, the record date for Alphabet’s upcoming dividend, as they look for clues on how leadership will manage cash returns alongside the company’s $175 billion–$185 billion capex ambitions.

Stock Market Today

  • Haemonetics Q1 Earnings Beat Estimates Amid Strong Medical Devices Sector Performance
    May 22, 2026, 10:52 PM EDT. Haemonetics (NYSE:HAE) posted a robust Q1 with revenues of $346.4 million, up 4.8% year on year and exceeding analyst forecasts by 2.6%. The medical devices & supplies specialty sector outperformed expectations, with revenues beating consensus by 5.2% overall. Haemonetics shares rose 10.6% post-earnings to $58.27, reflecting investor confidence. Industry growth drivers include an aging population increasing demand for blood-related medical products and advances in digital health technology, while challenges remain from pricing pressures and regulatory demands. The sector saw steady stock performance, up 3.6% on average following earnings releases. STAAR Surgical also delivered strong results, highlighting sector momentum.

Latest articles

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Stock Pauses as Nvidia Rally Cools Before Holiday

23 May 2026
IREN shares fell 2.1% to $56.83 Friday, ending a two-day rally but closing the week up 7.4%. The stock’s moves follow a $3.4 billion AI cloud deal with Nvidia and a $3 billion convertible note offering. March-quarter revenue dropped to $144.8 million, with a net loss of $247.8 million. U.S. markets close Monday for Memorial Day; trading resumes Tuesday.
AXT stock reaches record; investors weigh risk to rally

AXT stock reaches record; investors weigh risk to rally

23 May 2026
AXT shares jumped 16.37% to $140.83 on Friday, hitting a 52-week high and trading above all recent analyst targets. The surge followed strong demand for AI-linked optical networking hardware and a sharp rise in indium phosphide orders. First-quarter revenue climbed to $26.9 million, with gross margin turning positive. Management forecast Q2 profitability and a backlog over $100 million.
Plug Power stock back in play as Feb. 17 share-vote redo nears
Previous Story

Plug Power stock back in play as Feb. 17 share-vote redo nears

Exxon Mobil stock hits a fresh 52-week high as oil firms — what to watch next
Next Story

Exxon Mobil stock hits a fresh 52-week high as oil firms — what to watch next

Go toTop